Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
ATAD5 protein, partial | 4 | 0 | 0 | 4 |
GLS protein | 8 | 0 | 0 | 8 |
Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
Smad3 | 6 | 0 | 0 | 6 |
aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 6 | 0 | 0 | 6 |
progesterone receptor | 6 | 0 | 0 | 6 |
EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 7 | 0 | 0 | 7 |
thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 0 | 0 | 6 |
ATP-binding cassette sub-family C member 3 | 0 | 10 | 0 | 10 |
Multidrug resistance-associated protein 4 | 0 | 10 | 0 | 10 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 12 | 0 | 3 | 0 | 4 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 6 | 0 | 7 |
Carbonic anhydrase 2 | 0 | 6 | 0 | 8 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 2 | 1 | 4 |
Cytochrome P450 1A2 | 0 | 3 | 1 | 5 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 4 |
Cytochrome P450 3A4 | 0 | 6 | 0 | 6 |
Cytochrome P450 2D6 | 0 | 3 | 1 | 4 |
Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 0 | 0 | 6 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 0 | 0 | 6 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 0 | 0 | 6 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 5 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 0 | 0 | 6 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 4 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 0 | 0 | 6 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 4 |
GABA theta subunit | 6 | 0 | 0 | 6 |
Canalicular multispecific organic anion transporter 1 | 0 | 10 | 0 | 10 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 13 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 0 | 0 | 6 |
Carbonic anhydrase 14 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 4 |
toxin B | 0 | 0 | 0 | 1 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
Thymidine kinase | 0 | 2 | 0 | 3 |
thioredoxin reductase | 9 | 0 | 0 | 9 |
phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
TDP1 protein | 9 | 0 | 0 | 9 |
arylsulfatase A | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
Histone H2A.x | 4 | 0 | 0 | 4 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 10 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 5 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
AR protein | 11 | 0 | 0 | 11 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 10 | 3 | 17 |
Muscarinic acetylcholine receptor M4 | 0 | 9 | 1 | 12 |
Muscarinic acetylcholine receptor M1 | 0 | 10 | 1 | 14 |
Muscarinic acetylcholine receptor M3 | 0 | 8 | 1 | 12 |
Muscarinic acetylcholine receptor M4 | 0 | 8 | 1 | 12 |
Muscarinic acetylcholine receptor M5 | 0 | 7 | 1 | 11 |
Muscarinic acetylcholine receptor M5 | 0 | 9 | 1 | 12 |
Muscarinic acetylcholine receptor M2 | 0 | 9 | 2 | 15 |
Muscarinic acetylcholine receptor M1 | 0 | 10 | 3 | 17 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 9 | 1 | 12 |
Alpha-1D adrenergic receptor | 0 | 8 | 1 | 9 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 3 | 0 | 1 | 5 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 2 | 3 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 2 | 2 | 4 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
acetylcholinesterase | 4 | 0 | 0 | 4 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
Thrombopoietin | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 6 | 0 | 0 | 6 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
G | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
polyprotein | 3 | 0 | 0 | 3 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
Snq2p | 0 | 0 | 0 | 1 |
caspase-3 | 2 | 0 | 0 | 2 |
IDH1 | 4 | 0 | 0 | 4 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
Caspase-7 | 1 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
caspase-3 | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 8 | 0 | 0 | 8 |
geminin | 11 | 0 | 0 | 11 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
Albumin | 0 | 1 | 2 | 3 |
Albumin | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
Major prion protein | 0 | 0 | 1 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 1 | 1 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 5 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 1 | 4 |
Alpha-2A adrenergic receptor | 0 | 6 | 1 | 7 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 2 | 1 | 3 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 5 | 0 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 4 |
Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 6 | 1 | 7 |
Alpha-2C adrenergic receptor | 0 | 6 | 1 | 7 |
D | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 7 | 1 | 8 |
Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 5 | 0 | 7 |
D(4) dopamine receptor | 0 | 2 | 0 | 3 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 6 | 1 | 7 |
Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
Histamine H2 receptor | 0 | 3 | 2 | 5 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1B | 0 | 7 | 1 | 8 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 1 | 4 |
Histamine H1 receptor | 0 | 2 | 2 | 4 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 4 | 2 | 6 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 3 |
D(3) dopamine receptor | 0 | 6 | 0 | 7 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 4 | 1 | 5 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Spike glycoprotein | 7 | 1 | 1 | 9 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
D(2) dopamine receptor | 0 | 4 | 0 | 5 |
Calmodulin | 0 | 1 | 1 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 6 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 3 |
Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 3 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 1 | 1 | 3 |
Adenosine receptor A2a | 0 | 2 | 1 | 6 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Nischarin | 0 | 1 | 0 | 1 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 1 | 2 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Transporter | 0 | 3 | 1 | 5 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
ORF73 | 0 | 0 | 1 | 1 |
Adenylate cyclase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
Motilin receptor | 0 | 0 | 1 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Motilin receptor | 0 | 1 | 1 | 2 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 1 | 2 |
30S ribosomal protein S7 | 0 | 1 | 1 | 2 |
50S ribosomal protein L15 | 0 | 1 | 1 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 1 | 2 |
50S ribosomal protein L11 | 0 | 1 | 1 | 2 |
50S ribosomal protein L7/L12 | 0 | 1 | 1 | 2 |
50S ribosomal protein L19 | 0 | 1 | 1 | 2 |
50S ribosomal protein L1 | 0 | 1 | 1 | 2 |
50S ribosomal protein L20 | 0 | 1 | 1 | 2 |
50S ribosomal protein L27 | 0 | 1 | 1 | 2 |
50S ribosomal protein L28 | 0 | 1 | 1 | 2 |
50S ribosomal protein L29 | 0 | 1 | 1 | 2 |
50S ribosomal protein L31 | 0 | 1 | 1 | 2 |
50S ribosomal protein L31 type B | 0 | 1 | 1 | 2 |
50S ribosomal protein L32 | 0 | 1 | 1 | 2 |
50S ribosomal protein L33 | 0 | 1 | 1 | 2 |
50S ribosomal protein L34 | 0 | 1 | 1 | 2 |
50S ribosomal protein L35 | 0 | 1 | 1 | 2 |
50S ribosomal protein L36 | 0 | 1 | 1 | 2 |
30S ribosomal protein S10 | 0 | 1 | 1 | 2 |
30S ribosomal protein S11 | 0 | 1 | 1 | 2 |
30S ribosomal protein S12 | 0 | 1 | 1 | 2 |
30S ribosomal protein S13 | 0 | 1 | 1 | 2 |
30S ribosomal protein S16 | 0 | 1 | 1 | 2 |
30S ribosomal protein S18 | 0 | 1 | 1 | 2 |
30S ribosomal protein S19 | 0 | 1 | 1 | 2 |
30S ribosomal protein S20 | 0 | 1 | 1 | 2 |
30S ribosomal protein S2 | 0 | 1 | 1 | 2 |
30S ribosomal protein S3 | 0 | 1 | 1 | 2 |
30S ribosomal protein S4 | 0 | 1 | 1 | 2 |
30S ribosomal protein S5 | 0 | 1 | 1 | 2 |
30S ribosomal protein S8 | 0 | 1 | 1 | 2 |
30S ribosomal protein S9 | 0 | 1 | 1 | 2 |
50S ribosomal protein L13 | 0 | 1 | 1 | 2 |
50S ribosomal protein L14 | 0 | 1 | 1 | 2 |
50S ribosomal protein L16 | 0 | 1 | 1 | 2 |
50S ribosomal protein L23 | 0 | 1 | 1 | 2 |
30S ribosomal protein S15 | 0 | 1 | 1 | 2 |
50S ribosomal protein L17 | 0 | 1 | 1 | 2 |
50S ribosomal protein L21 | 0 | 1 | 1 | 2 |
50S ribosomal protein L30 | 0 | 1 | 1 | 2 |
50S ribosomal protein L6 | 0 | 1 | 1 | 2 |
30S ribosomal protein S14 | 0 | 1 | 1 | 2 |
30S ribosomal protein S17 | 0 | 1 | 1 | 2 |
30S ribosomal protein S1 | 0 | 1 | 1 | 2 |
50S ribosomal protein L18 | 0 | 1 | 1 | 2 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Chitinase B | 0 | 1 | 0 | 1 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 1 | 2 |
50S ribosomal protein L3 | 0 | 1 | 1 | 2 |
50S ribosomal protein L24 | 0 | 1 | 1 | 2 |
50S ribosomal protein L4 | 0 | 1 | 1 | 2 |
50S ribosomal protein L22 | 0 | 1 | 1 | 2 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 1 | 2 |
30S ribosomal protein S21 | 0 | 1 | 1 | 2 |
50S ribosomal protein L25 | 0 | 1 | 1 | 2 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 1 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Luciferase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
GALC protein | 2 | 0 | 0 | 2 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 3 | 0 | 5 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
PPM1D protein | 1 | 0 | 0 | 1 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
TSHR protein | 1 | 0 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Cytochrome P450 2A6 | 0 | 3 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 2 | 5 |
Translocator protein | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 2 | 5 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 5 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Cytochrome P450 2A13 | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Integrin beta | 0 | 0 | 1 | 1 |
Glycoprotein IIb | 0 | 0 | 1 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 4 |
Endolysin | 0 | 0 | 1 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 2 | 5 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 1 | 5 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidylate synthase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
guanine nucleotide-binding protein subunit alpha-15 | 0 | 1 | 1 | 2 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
trace amine-associated receptor 1 | 0 | 1 | 1 | 2 |
Phenylethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |